We are live on ! Find out more
SAGE

Sage Therapeutics
SAGE

Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

137 hedge funds and large institutions have $1.37B invested in Sage Therapeutics in 2015 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 53 increasing their positions, 41 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 41

20% more funds holding in top 10

Funds holding in top 10: 5 → 6 (+1)

19% more capital invested

Capital invested by funds: $1.15B → $1.37B (+$217M)

17% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 23

2% more funds holding

Funds holding: 134 → 137 (+3)

25% less call options, than puts

Call options by funds: $5.22M | Put options by funds: $6.95M

Holders
137
Holders Change
+3
Holders Change %
+2.24%
% of All Funds
3.59%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.16%
New
27
Increased
53
Reduced
41
Closed
23
Calls
$5.22M
Puts
$6.95M
Net Calls
-$1.73M
Net Calls Change
-$7.77M

Top Buyers

Rank Fund Capital Flow
1
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$41.4M
2
BB
BB Biotech
Switzerland
+$35.1M
3
Millennium Management
Millennium Management
New York
+$25.7M
4
Jennison Associates
Jennison Associates
New York
+$12.6M
5
Bank of New York Mellon
Bank of New York Mellon
New York
+$11.3M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$17.3M
2
GGHC
Gilder Gagnon Howe & Co
New York
-$15.1M
3
RG
Redmile Group
California
-$9.14M
4
HLA
Hamilton Lane Advisors
Pennsylvania
-$6.74M
5
O
OrbiMed
New York
-$6.35M
Name Holding Trade Value Shares
Change 		Change in
Stake
Federated Hermes
26
Federated Hermes
Pennsylvania
$12M +$14.9K +300 +0.1%
GTC
27
Ghost Tree Capital
New York
$11.7M +$7.89M +159,200 +390%
HCMT
28
Highland Capital Management (Texas)
Texas
$8.92M +$7.58M +152,985 New
Northern Trust
29
Northern Trust
Illinois
$8.84M +$318K +6,414 +4%
CC
30
Casdin Capital
New York
$8.34M +$7.08M +143,011 New
EAM
31
Eventide Asset Management
Massachusetts
$7.34M +$332K +6,700 +6%
Norges Bank
32
Norges Bank
Norway
$7.03M +$3.02M +60,953 +102%
BA
33
BlackRock Advisors
Delaware
$6.9M -$162K -3,267 -3%
OAM
34
Oxford Asset Management
United Kingdom
$6.75M +$5.74M +115,936 New
BBA
35
Baker Bros. Advisors
New York
$6.12M – – –
HP
36
Harbourvest Partners
Massachusetts
$6.1M -$2.94M -59,251 -36%
OM
37
Opaleye Management
Massachusetts
$5.83M +$3.96M +80,000 +400%
TCM
38
Tekla Capital Management
Massachusetts
$5.7M – – –
UBS AM
39
UBS AM
Illinois
$5.42M +$2.03M +40,904 +79%
SFM
40
Sphera Funds Management
Israel
$5.42M +$4.21M +85,000 +1,063%
Geode Capital Management
41
Geode Capital Management
Massachusetts
$4.7M +$263K +5,313 +7%
GH
42
GAM Holding
Switzerland
$4.63M +$1.67M +33,800 +74%
AP
43
AlpInvest Partners
Netherlands
$4.58M -$748K -15,100 -16%
CS
44
Candriam SCA
Luxembourg
$4.44M +$495K +10,000 +15%
GC
45
Guggenheim Capital
Illinois
$4.03M -$1.73M -35,003 -34%
Bank of America
46
Bank of America
North Carolina
$3.66M +$1.36M +27,545 +78%
NIP
47
Nicholas Investment Partners
California
$3.6M -$364K -7,338 -11%
HTC
48
Hershey Trust Company
Pennsylvania
$3.44M +$987K +19,920 +51%
Lazard Asset Management
49
Lazard Asset Management
New York
$3.34M -$254K -5,125 -8%
PMAM
50
Picton Mahoney Asset Management
Ontario, Canada
$3.33M -$981K -19,800 -26%
1
2
3 4 5

SAGE Hedge Fund Activity: Q4 2015 in Review

137 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q4 2015, worth a combined $1.37B — up 19% from $1.15B a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new SAGE positions and 23 closed out — a net gain of 4 holders — while 53 added to existing stakes and 41 trimmed.

The largest buyer was Lord, Abbett & Co, adding an estimated $41.4M. The largest seller was T. Rowe Price Associates, cutting an estimated $17.3M.

  • 137 institutional investors held Sage Therapeutics (SAGE) as of Q4 2015, up from 134 in Q3 2015.
  • Funds reported $1.37B of Sage Therapeutics stock for Q4 2015, up 19% quarter-over-quarter.
  • 27 funds opened new Sage Therapeutics positions in Q4 2015 and 23 closed out, a net change of +4 holders.
  • The largest Sage Therapeutics buyer in Q4 2015 was Lord, Abbett & Co, an estimated $41.4M added.
  • The largest Sage Therapeutics seller in Q4 2015 was T. Rowe Price Associates, an estimated $17.3M sold.

Based on aggregated 13F filings for Q4 2015.